{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:44:00Z","timestamp":1791146640698,"version":"4.1.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Colistin has found increasing use in treating drug-resistant bacterial lung infections, but potential interactions with pulmonary biomolecules have not been investigated. We postulated that colistin, like aminoglycoside antibiotics, may bind to secretory mucin in sputum or epithelial mucin that lines airways, reducing free drug levels. To test this hypothesis, we measured binding of colistin and other antibiotics to porcine mucin, a family of densely glycosylated proteins used as a surrogate for human sputum and airway mucin. Antibiotics were incubated in dialysis tubing with or without mucin, and concentrations of unbound antibiotics able to penetrate the dialysis tubing were measured over time using liquid chromatography-tandem mass spectrometry (LC-MS\/MS). The percentage of antibiotic measured in the dialysate after 4 h in the presence of mucin, relative to the amount without mucin, was 15% for colistin, 16% for polymyxin B, 19% for tobramycin, 52% for ciprofloxacin, and 78% for daptomycin. Antibiotics with the strongest mucin binding had an overall polybasic positive charge, whereas those with comparatively little binding were less basic. When comparing MICs measured with or without added mucin, colistin and polymyxin B showed &gt;100-fold increases in MICs for multiple Gram-negative bacteria. Preclinical evaluation of mucin binding should become a standard procedure when considering the potential pulmonary use of new or existing antibiotics, particularly those with a polybasic overall charge. In the airways, mucin binding may reduce the antibacterial efficacy of inhaled or intravenously administered colistin, and the presence of sub-MIC effective antibiotic concentrations could result in the development of antibiotic resistance.<\/jats:p>","DOI":"10.1128\/aac.00808-15","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T02:24:44Z","timestamp":1436840684000},"page":"5925-5931","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":109,"title":["Mucin Binding Reduces Colistin Antimicrobial Activity"],"prefix":"10.1128","volume":"59","author":[{"given":"Johnny X.","family":"Huang","sequence":"first","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A. T.","family":"Blaskovich","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Pelingon","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Ramu","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysha G.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Butler","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Bruce","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Cardeas Pharma, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu213"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit367"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit522"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70580-1"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/19.6.831"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.16d30.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-015-0072-9"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.11.004"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2208OC"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.10.011"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt207"},{"key":"e_1_3_2_13_2","unstructured":"National Institutes of Health. April 2015. ClinicalTrials.gov identifier NCT01863719: aerosolized and intravenous colistin in healthy adults. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01863719."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.11.021"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2006.10.010"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2004.10.001"},{"key":"e_1_3_2_17_2","volume-title":"51st Intersci Conf Antimicrob Agents Chemother, 17 to 20 September 2011","author":"Das D","year":"2011","unstructured":"Das D, Buyck J, Van Bambeke F, Lorent J, Mingeot-Leclercq M, Gobin P, Couet W, Tulkens PM. 2011. Comparative assessment of antibacterial and cytotoxic effects of colistin (CST) colistin methanesulfonate (CMS) and polymyxin B (PMB) using Pseudomonas aeruginosa, macrophages and renal cells, and liposomes, abstr F2-170. 51st Intersci Conf Antimicrob Agents Chemother, 17 to 20 September 2011, Chicago, IL. http:\/\/www.abstractsonline.com\/plan\/ViewAbstract.aspx?mID=2789&sKey=5b319c87-0c75-4ca9-9ee9-762aa8a4a65c&cKey=e1f391f6-ef61-4e88-8613-537cbdfd7a9e&mKey=0c918954-d607-46a7-8073-44f4b537a439."},{"key":"e_1_3_2_18_2","volume-title":"28-day inhalation toxicology of polymyxin E1, the major active component of colistin, in rats and dogs","author":"VanDevanter DR","year":"2001","unstructured":"VanDevanter DR, Rose LM, Sprugel KH. 2001. 28-day inhalation toxicology of polymyxin E1, the major active component of colistin, in rats and dogs, poster P236. 24th European Cystic Fibrosis Congress, Vienna, Austria."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(02)00044-9"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2003.12.005"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc071717"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki461"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.1.184"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199912000-00007"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00103-08"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.1.34"},{"key":"e_1_3_2_27_2","first-page":"761","article-title":"Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum","volume":"132","author":"Mendelman PM","year":"1985","unstructured":"Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. 1985. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis 132:761\u2013765.","journal-title":"Am Rev Respir Dis"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00248-09"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.4.483"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01705-13"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0412"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02713541","article-title":"Biochemical definition of human tracheobronchial mucus","volume":"154","author":"Roussel P","year":"1978","unstructured":"Roussel P, Degand P, Lamblin G, Laine A, Lafitte JJ. 1978. Biochemical definition of human tracheobronchial mucus. Lung 154:241\u2013260.","journal-title":"Lung"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45969-0"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn176"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2007.01.006"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.1998.00379.x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00330.2007"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0070-2153(04)64003-8"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/26.suppl_F.165","article-title":"Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches","volume":"26","author":"Ball P","year":"1990","unstructured":"Ball P. 1990. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches. J Antimicrob Chemother 26(Suppl F):165\u2013179.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3270"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.08.025"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/430352"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20938"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70850-3"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.78"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ048"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00808-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00808-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:48:29Z","timestamp":1645483709000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00808-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1128\/AAC.00808-15"],"URL":"https:\/\/doi.org\/10.1128\/aac.00808-15","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"2015-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-09-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}